Category:

European Union nations have until August 20 to suspend the sale of some 700 generic drugs made in India,...after an Indian firm contracted by drug companies to test the medications was found to have manipulated data...On-site verifications....showed irregularities "in each and every one of the nine trials inspected,"

Immunotherapies are dangling on the edge of a treatment paradigm shift, potentially slipping into the first-line option spot where cytotoxic chemotherapies have been comfortably seated for some time. The promise of immunotherapies, ranging from monoclonal antibodies to interferons and checkpoint inhibitors, has to do with target specificity to reduce toxicity.

Express Scripts.., the largest pharmacy benefit manager in the United States,...said the cost of potent new cholesterol drugs called PCSK9 inhibitors could "wreak financial havoc" among its clients.

Fallon general surgeon Lisa Rasmussen, MD, received recognition…for outstanding customer experience provided to patients…works at Banner Health Clinic specializing in general surgery, and practices at Banner Churchill Community Hospital....

Expectations in the drug business have been getting extremely high. Hepatitis C drugs are generating some of the biggest annual sales ever. New medicines from Merck and Bristol-Myers Squibb that harness the immune system to fight tumors are generating huge excitement. For a quick sense of what is possible in the pharmaceutical industry, here are the top drug launches of all time,..

Pfizer… won’t bring an over-the-counter version of its cholesterol pill Lipitor to the U.S. market, after a trial found that patients couldn’t take the drug correctly without a doctor’s help…. trial looked at whether (patients)… would check their cholesterol after starting the drug, and take the right medical action after getting the results. The tests found that they couldn’t.

"Americans cannot afford to rely on 20th century methodologies for treatments when the world is on the cutting edge of new medical technologies. Federal agencies must be equipped to keep the U.S. at the forefront of medical innovation."… much of the report focuses on improving the FDA’s ability to work more quickly to evaluate and approve new devices and therapies.

market for the new class of hepatitis-C drugs is becoming more crowded as a higher percentage of patients seek out therapies with shorter treatment durations and drugmakers pursue indications for more stubborn forms of the infection...

People who avoid taking statins for managing high cholesterol face hurdles to costly new treatments…powerful new class of drugs promises to change the management of heart disease for high-risk patients who struggle to get their cholesterol levels under control…only some of them are likely to get the new medicines.

National Institute of Standards and Technology,…has unveiled its long-awaited mobile security guide, specifically written for safeguarding medical data… myriad reasons for compiling such a guide…"many healthcare providers are using mobile devices in healthcare delivery before they have appropriate privacy and security protections in place."